Pipeline

Main Pipeline

Project Code Molecule Type Target Indication Development

YBL-001

Antibody-Drug Conjugate

DLK-1

Oncology

Preclinical

YBL-006

Antibody

Inhibition PD-1 and PD-L1 interaction

Immuno-oncology

Preclinical

YBL-007

Antibody

Inhibition PD-1 and PD-L1 interaction

Immuno-oncology

Cell Line Development

YBL-011

Antibody

Inhibition of LAG-3 and MHC class II interaction

Immuno-oncology

Cell Line Development

YBL-013

Bispecific Antibodies(ALiCE)

PD-L1 & CD3/ Cell Engager

Immuno-oncology

Cell Line Development